ABVC - ABVC BIOPHARMA, INC.
0.9094
-0.091 -9.963%
Share volume: 98,245
Last Updated: 03-30-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$1.00
-0.09
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-17-2024 | 08-14-2024 | 11-14-2024 | 04-30-2025 | 08-13-2025 | 10-31-2025 | 03-03-2026 | |
| Assets | ||||||||
| Total Assets | 14.460 M | 14.634 M | 14.463 M | 14.876 M | 16.241 M | 21.176 M | 21.062 M | |
| Current Assets | 1.794 M | 2.190 M | 2.148 M | 1.470 M | 2.770 M | 4.073 M | 2.501 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 11.460 K | 11.460 K | 11.460 K | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 75.916 K | 75.683 K | 70.809 K | 65.052 K | 65.211 K | 65.175 K | 64.354 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 30.489 K | 124.296 K | 137.344 K | 152.206 K | 388.251 K | 192.068 K | 681.480 K | |
| Total Non-current Assets | 3.749 M | 3.652 M | 3.614 M | 3.885 M | 3.963 M | 2.745 M | 1.878 M | |
| Property Plant Equipment | 7.949 M | 7.929 M | 7.931 M | 8.169 M | 8.215 M | 12.056 M | 12.835 M | |
| Other Assets | 4.717 M | 4.515 M | 4.507 M | 5.237 M | 5.255 M | 5.048 M | 5.725 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 14.460 M | 14.634 M | 14.463 M | 14.876 M | 16.241 M | 21.176 M | 21.062 M | |
| Total liabilities | 6.973 M | 6.805 M | 6.484 M | 6.919 M | 6.751 M | 6.684 M | 7.765 M | |
| Total current liabilities | 6.634 M | 6.549 M | 6.316 M | 6.731 M | 6.533 M | 6.508 M | 6.164 M | |
| Accounts Payable | 4.051 M | 3.961 M | 3.633 M | 3.827 M | 4.291 M | 3.991 M | 4.162 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.792 M | 8.262 M | 8.358 M | 5.404 M | 7.014 M | 12.058 M | 11.112 M | |
| Common stock | 86.040 M | 87.095 M | 87.321 M | 83.631 M | 86.398 M | 93.139 M | 96.033 M | |
| Retained earnings | -69.353 M | -70.366 M | -70.552 M | -69.792 M | -72.049 M | -73.295 M | -76.858 M |